Validation of EORTC prognostic factors for adults with low-grade glioma: A report using intergroup 86-72-51

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 1, 2011, Pages 218-224

  Daniels, Thomas B ^a   Brown, Paul D ^a   Felten, Sara J ^a   Wu, Wenting ^a   Buckner, Jan C ^a   Arusell, Robert M ^b   Curran, Walter J ^c   Abrams, Ross A ^d   Schiff, David ^e   Shaw, Edward G ^f  

^a MAYO CLINIC   (United States)

^b MeritCare Roger Maris Cancer Center   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d RUSH UNIVERSITY   (United States)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Low grade glioma; Prognostic factors; Radiotherapy

Indexed keywords

ASTROCYTOMA; DATA SETS; GENETIC DATA; LOW-GRADE GLIOMAS; MULTI VARIATE ANALYSIS; OVERALL SURVIVAL; PATIENT DATA; PROGNOSTIC FACTORS; PROGRESSION FREE SURVIVAL; RISK FACTORS; SURGICAL RESECTION; TUMOR SIZE; UNIVARIATE ANALYSIS;

DISEASES; HISTOLOGY; HOSPITAL DATA PROCESSING; MULTIVARIANT ANALYSIS; RADIOTHERAPY;

TUMORS;

ADULT; ADULT DISEASE; AGE; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 1P; CHROMOSOME DELETION; CLINICAL STUDY; EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER; FEMALE; FOLLOW UP; GLIOMA; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LOW GRADE GLIOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINI MENTAL STATUS EXAMINATION; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ASTROCYTOMA; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GLIOMA; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SUPRATENTORIAL NEOPLASMS; TUMOR BURDEN; YOUNG ADULT;

EID: 79961129343     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.003     Document Type: Article

References (20)

1. G. Bauman, K. Lote, and D. Larson Pretreatment factors predict overall survival for patients with low-grade glioma: A recursive partitioning analysis Int J Radiat Oncol Biol Phys 45 1999 923 929 (Pubitemid 29525456)
2. C. Leighton, B. Fisher, and G. Bauman Supratentorial low-grade glioma in adults: An analysis of prognostic factors and timing of radiation J Clin Oncol 15 1997 1294 1301 (Pubitemid 27167360)
3. A.B. Karim, B. Maat, and R. Hatlevoll A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 Int J Radiat Oncol Biol Phys 36 1996 549 556 (Pubitemid 26404297)
4. A.B. Karim, D. Afra, and P. Cornu Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis Int J Radiat Oncol Biol Phys 52 2002 316 324 (Pubitemid 34170840)
5. M.J. van den Bent, D. Afra, and O. de Witte Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial Lancet 366 2005 985 990 (Pubitemid 41323034)
6. F. Pignatti, M. van den Bent, and D. Curran Prognostic factors for survival in adult patients with cerebral low-grade glioma J Clin Oncol 20 2002 2076 2084 (Pubitemid 34408798)
7. E. Shaw, R. Arusell, and B. Scheithauer Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: Initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study J Clin Oncol 20 2002 2267 2276 (Pubitemid 34441653)
8. R.B. Jenkins, H. Blair, and K.V. Ballman A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma Cancer Res 66 2006 9852 9861 (Pubitemid 44672036)
9. D. Cox Regression models and life-tables J R Stat Soc [B] 34 1972 187 220
10. M. LeBlanc, and J. Crowley Relative risk trees for censored survival data Biometrics 48 1992 411 425
11. R. Stupp, R.C. Janzer, M.E. Hegi, J.G. Villemure, and R.O. Mirimanoff Prognostic factors for low-grade gliomas Semin Oncol 30 Suppl. 19 2003 23 28 (Pubitemid 38199160)
12. K. Lote, T. Egeland, and B. Hager Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: A retrospective study in 379 patients J Clin Oncol 15 1997 3129 3140 (Pubitemid 27377505)
13. S.A. Yeh, J.T. Ho, C.C. Lui, Y.J. Huang, C.Y. Hsiung, and E.Y. Huang Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas Br J Radiol 78 2005 230 235
14. A. Nicolato, M.A. Gerosa, P. Fina, P. Iuzzolino, F. Giorgiutti, and A. Bricolo Prognostic factors in low-grade supratentorial astrocytomas: A uni-multivariate statistical analysis in 76 surgically treated adult patients Surg Neurol 44 1995 208 221 discussion 221-203
15. J.P. Knisely, B.E. Lally, and D. Zelterman Validation of the European Organization for Research and Treatment of Cancer (EORTC) Prognostic factors for low grade gliomas utilizing the Surveillance, Epidemiology, and End Results (SEER) database [Abstract] Int J Radiat Oncol Biol Phys 63 Suppl. 1 2005 S262 S263
16. P.D. Brown, J.C. Buckner, and J.R. O'Fallon Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma Int J Radiat Oncol Biol Phys 59 2004 117 125 (Pubitemid 38501515)
17. J. Felsberg, A. Erkwoh, and M.C. Sabel Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival Brain Pathol 14 2004 121 130 (Pubitemid 38656383)
18. G.S. Bauman, Y. Ino, and K. Ueki Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas Int J Radiat Oncol Biol Phys 48 2000 825 830
19. L. Mariani, G. Deiana, and E. Vassella Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy J Clin Oncol 24 2006 4758 4763 (Pubitemid 46630940)
20. H. Yan, D.W. Parsons, and G. Jin IDH1 and IDH2 mutations in gliomas N Engl J Med 360 2009 765 773